Patients First Act of 2019
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Patients First Act of 2019
This bill requires the National Institutes of Health (NIH) to support stem cell research. Specifically, the NIH must conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions. However, such techniques must not involve (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill.
The NIH must also report on peer-reviewed stem cell research proposals that were not funded.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 64: Patients First Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-64/
"H.R. 64: Patients First Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-64/.
H.R. 64, 116th Cong. (2026), https://openamerica.io/bill/116-HR-64/.
[H.R. 64: Patients First Act of 2019](https://openamerica.io/bill/116-HR-64/)